The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting
· Issued by Tanvex BioPharma, Inc.
Close
Today's Information
Provided by: Tanvex BioPharma, Inc.
SEQ_NO
1
Date of announcement
2022/06/17
Time of announcement
16:32:41
Subject
The Announcement of Resolutions of 2022
Annual General Shareholders' Meeting
Date of events
2022/06/17
To which item it meets
paragraph 18
Statement
1.Date of the shareholders meeting:2022/06/17
2.Important resolutions (1)Profit distribution/ deficit
compensation:Acknowledgment of 2021 loss make-up
3.Important resolutions (2)Amendments to the corporate charter:
Approved the amendment to the"Memorandum and Articles of Association."
of the Company.
4.Important resolutions (3)Business report and financial statements:
Approved the 2021 Business Report and Consolidated Financial Report
5.Important resolutions (4)Elections for board of directors and
supervisors:
Approve of by-election for one independent director.
6.Important resolutions (5)Any other proposals:
(1)Approved the amendment to the "Procedures for the Acquisition
or Disposal of Assets" of the Company.
(2)Approved the amendment to the Rules of Procedure for Shareholders'
Meeting of the Company.
(3)Approved to release the prohibition on new Independent Director from
participation in competitive business.
(4)Approve the issuance of 2022 Employees' Restricted Share Awards.
7.Any other matters that need to be specified:None
